Surgery to treat rectal cancer

Surgery to treat rectal cancer.

For many rectal cancer patients, the aspect of surgery is a worrisome reality, given that the manipulation can significantly impair both bowel and sexual function. However, a additional study reveals that some cancer patients may fare just as well by forgoing surgery in favor of chemotherapy/radiation and "watchful waiting". The conclusion is based on a review of data from 145 rectal cancer patients, all of whom had been diagnosed with originate I, II or III disease All had chemotherapy and radiation.

But about half had surgery while the others staved off the conduct in favor of rigorous tracking of their disease extension - sometimes called "watchful waiting womens. We believe that our results will encourage more doctors to judge this 'watch-and-wait' approach in patients with clinical complete response as an alternative to immediate rectal surgery, at least for some patients," superior study author Dr Philip Paty said in a tidings release from the American Society of Clinical Oncology (ASCO).

So "From my experience, most patients are avid to accept some risk to defer rectal surgery in hope of avoiding major surgery and preserving rectal function," said Paty, a surgical oncologist at the Memorial Sloan-Kettering Cancer Center in New York City. The findings are to be presented Monday at the Gastrointestinal Cancers Symposium in San Francisco. ASCO is one of four organizations sponsoring the symposium. Research presented at medical meetings should be viewed as prodromic until published in a peer-reviewed journal.

The learning authors said that the ilk of patients who would most disposed to do well without automatic surgery are the up to 50 percent of stage I patients whose tumors typically perish altogether following initial chemotherapy/radiation treatment. That figure hovers at between 30 percent and 40 percent among stage II and III patients. The budding investigation looked at the experience of rectal cancer patients who were treated between 2006 and 2014 at Memorial Sloan-Kettering.

While all the patients had practised complete tumor regression following chemotherapy/radiation, only some underwent present rectal surgery. The other 73 patients were instead followed with "watchful waiting," which involved support exams every few months. Ultimately, nearly three-quarters of the non-surgery group remained cancer-free approximately four years later, while about one spot had to undergo surgery to treat tumor recurrence Overall, the four-year survival rebuke was 91 percent in the no-surgery group vs 95 percent in the surgery group.

tag : surgery patients rectal cancer percent radiation chemotherapy group waiting

Post a comment

Private comment



Welcome to FC2!

Latest journals
Latest comments
Latest trackbacks
Monthly archive
Search form
Display RSS link.
Friend request form

Want to be friends with this user.